Novo Holdings A/S - 25 Jul 2024 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
10%+ Owner
Signature
/s/ Barbara Fiorini Due, General Counsel, Finance & Operations
Issuer symbol
IOBT
Transactions as of
25 Jul 2024
Net transactions value
-$99,125
Form type
4
Filing time
26 Jul 2024, 21:22:20 UTC
Previous filing
14 May 2024
Next filing
27 Oct 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IOBT COMMON STOCK Sale $68,339 -51,522 -1.2% $1.33 4,377,927 25 Jul 2024 Direct F1
transaction IOBT COMMON STOCK Sale $30,787 -23,478 -0.54% $1.31 4,354,449 26 Jul 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Novo Holdings A/S is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.29 to $1.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.28 to $1.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.